FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency

FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency

Updated FAQs for Opioid Use Disorder Prescribing and Dispensing in the COVID-19 Emergency

In response to the novel Coronavirus Disease (COVID-19) pandemic, SAMHSA is providing updates to Frequently Asked Questions (FAQs) regarding the provision of methadone and buprenorphine for the treatment of opioid use disorder for new and existing patients.